Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
height and weight, but that doesnt tell the whole story, right
SURMOUNT-1 enrolled 2,539 adults with obesity or overweight with at least one weight-related complication
Tirzepatide Versus Semaglutide In the open-label SURPASS-2 study, patients were randomised to once weekly tirzepatide 5, 10 or 15 mg (blinded) versus semaglutide 1 mg, all with background metformin (minimum 1500 mg/day) for 40 weeks
We simplify the process by accepting all major insurance plans and taking charge of the potentially cumbersome prior authorization process
Its more likely during the initial adjustment phase or if blood sugar levels drop too low
PMID: 31235357
US$ 29.25
US$ 20.34
US$ 22.13
